Jorge S. Martins
About Jorge S. Martins
Jorge S. Martins is a Postdoctoral Research Associate at Yale University, focusing on the pathophysiology of addiction and treatment outcomes. He has a background in psychology with advanced degrees from Universidade de Coimbra and the University of Missouri-Columbia.
Work at Yale University
Jorge S. Martins has been serving as a Postdoctoral Research Associate at Yale University since 2020. In this role, he conducts research focused on the pathophysiology of addiction and examines the heterogeneity in treatment outcomes. His work utilizes advanced neuroimaging tools, including fMRI, to identify clinical prognostic indicators related to addiction. Martins completed his postdoctoral training at Yale University in 2021.
Education and Expertise
Jorge S. Martins holds an Integrated Master's degree in Psychology from Universidade de Coimbra, which he completed from 2005 to 2010. He furthered his education at the University of Missouri-Columbia, where he earned a Master's degree in Psychology from 2014 to 2016 and a Ph.D. in Psychology from 2014 to 2020. His doctoral research focused on using EEG/ERPs to investigate the relationship between neurobehavioral traits, such as reward processing and cognitive control, in the context of addiction susceptibility.
Research Experience
Before joining Yale University, Jorge S. Martins worked at the University of Missouri-Columbia for six years, from 2014 to 2020. During this time, he served as a Graduate Student and as a Research Assistant from 2018 to 2020. His research primarily concentrated on alcohol use disorder as a model for studying addictive behaviors, contributing to a deeper understanding of addiction and its treatment outcomes.
Specialization in Addiction Studies
Jorge S. Martins specializes in the study of alcohol use disorder, focusing on its implications for understanding addictive behaviors. His research aims to explore the complexities of addiction, including the variability in treatment responses among individuals. By employing neuroimaging techniques, he seeks to uncover clinical prognostic indicators that can inform treatment strategies for addiction.